Blood lead (PbB) and erythrocyte delta-aminolevulinic acid dehydratase (ALAD) were measured in a group (A) of 50 mentally retarded children of unknown etiology (24 boys and 26 girls; average age 13.38 years, range 10-17 years) from an institution for handicapped children in Zagreb, and in a group (B) of 50 "normal" children (31 boys and 19 girls; average age 13.36 years, range 10-17 years) from a nearby orphanage in the same area (less polluted) of northern Zagreb. The children in group A had spent an average of 4.12 years (0.6-12 years) in the institution, and came from both urban (n = 23) and rural (n = 27) areas. The children in group B had spent an average of 4.88 years (1-14 years) in the orphanage, and also came from both urban (n = 38) and rural (n = 12) areas. The data obtained indicate a very close distribution of ALAD PbB levels in both groups, but a considerably different distribution of levels in favour of a lower activity in mentally retarded children. However, PbB and ALAD in both groups were within the range of currently acceptable "normal" values. The median and range values in groups A and B, respectively, were: 132 micrograms/l (85-256 micrograms/l) and 135 micrograms/l (78-215 micrograms/l) for PbB; 49.2 European units) (27.0-65.0 European units) and 54.6 European units (27.0-69.9 European units) for ALAD.(ABSTRACT TRUNCATED AT 250 WORDS)
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/BF02226901 | DOI Listing |
J Pathol
January 2025
Cardiorenal Translational Laboratory, Imas12 Research Institute, Hospital Universitario 12 de Octubre, Madrid, Spain.
Ischaemic heart disease (IHD) remains a major cause of death and morbidity. Klotho is a well-known anti-ageing factor with relevant cardioprotective actions, at least when renal dysfunction is present, but its actions are much less known when renal function is preserved. This study investigated Klotho as a biomarker and potential novel treatment of IHD-associated complications after myocardial infarction (MI) under preserved renal function.
View Article and Find Full Text PDFBMC Neurol
January 2025
Institute for Intensive Care Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Background: Delirium is a common complication in patients at the intensive care unit (ICU) and is associated with prolonged ICU-stay and hospitalization and with increased morbidity. The impact of ICU-delirium on long-term survival is not clearly understood.
Methods: This retrospective single center observational study was conducted at the Institute of Intensive Care Medicine at the University Hospital Zurich, Switzerland.
J Glaucoma
January 2025
Ophthalmology Unit, University Hospital Maggiore della Carità, Novara, Italy.
Prcis: Deep sclerectomy (DS) and canaloplasty provide better intraocular pressure (IOP) control than viscocanalostomy. DS required less glaucoma medications but more interventions to reach target IOP.
Purpose: To compare real-world outcomes of three non-penetrating glaucoma surgery (NPGS) techniques.
Iowa Orthop J
January 2025
Department of Orthopaedic Surgery and Rehabilitation Medicine, State University of New York (SUNY) Downstate Health Sciences University, Brooklyn, New York, USA.
Background: While prolonged operative time and increased levels fused have been shown to increase the risk of prolonged intensive care unit (ICU) length-of-stay (LOS), studies are limited in guiding decision-making regarding the need for intensive care postoperatively. This is especially the case among the cohort of adolescent idiopathic scoliosis (AIS) patients undergoing posterior spinal fusion (PSF); associations between comorbidities and ICU LOS are not well-delineated.
Methods: AIS patients who underwent PSF from January 1st, 2016 to December 1st, 2016 at 101 participating centers were identified using the American College of Surgeons (ACS) National Surgical Quality Im-provement Project (NSQIP) Pediatric database.
PLoS One
January 2025
Department of Experimental Oncology, European Institute of Oncology, IRCCS, Milano, Italy.
Background: Randomised trials conducted from 2006 to 2021 indicated that vitamin D supplementation (VDS) was able to prevent severe COVID-19 and acute respiratory infections (ARI). However, larger randomised trials published in 2022 did not confirm the health benefits of VDS in COVID-19 patients.
Objective: To examine through a systematic review with meta-analysis the characteristics of randomised trials on VDS to COVID-19 patients and admission to intensive care unit (ICU), and of randomised trials on VDS for the prevention of ARI.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!